EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Circulating extracellular vesicles drive innate immune dysregulation in MIS-C

Tugce Canavar Yildirim, Yasemin Ozsurekci, Muzaffer Yildirim, Volkan Yazar, Irem Evcili, Bilgi Gungor, Ismail Cem Yilmaz, Seza Ozen, Kubra Aykac, Ali Bulent Cengiz, Ulku Guler, Bekir Salih und 2 weitere

Journal of Allergy and Clinical Immunology · 2026

DOI: 10.1016/j.jaci.2026.02.048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Tugce Canavar Yildirim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Development Research Program, Dokuz Eylul University, Izmir Biomedicine and Genome Center, Izmir, Turkiye; Molecular Biology and Genetics Dep…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Extracellular Vesicles, Immunity, Innate. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: TÜBİTAK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a post-severe acute respiratory syndrome coronavirus 2 hyperinflammatory condition with multiorgan involvement. The contribution of circulating extracellular vesicles (EVs) to MIS-C immunopathology remains incompletely defined. OBJECTIVE: We sought to compare humoral and cytokine responses and EV-associated viral/inflammatory signatures in MIS-C versus pediatric coronavirus disease 2019 (COVID-19) across the clinical spectrum. METHODS: In a prospective cohort, children with PCR-confirmed severe acute respiratory syndrome coronavirus 2 infection were classified as asymptomatic, mild/moderate, or severe COVID-19 or MIS-C and compared with healthy controls. Serum anti-spike, anti-receptor-binding domain (RBD), and anti-nucleocapsid IgG/IgA/IgM were quantified by ELISA and followed longitudinally. Nineteen cytokines were measured using multiplex bead assays. Plasma EVs were isolated by size-exclusion chromatography, characterized by tunable resistive pulse sensing/flow cytometry, assessed for spike/RBD by immunoblotting, tested for nuclear factor κB (NF-κB)/interferon regulatory factor (IRF) activation in THP1 reporter cells, and profiled by LC-MS/MS proteomics. RESULTS: Patients with MIS-C had higher anti-spike/RBD IgG (and broader isotype responses) at admission and sustained titers over follow-up, consistent with prolonged antigenic exposure. MIS-C showed a distinct inflammatory profile with prominent IL-17A (and IL-22) elevation relative to severe COVID-19. Spike and RBD were detectable in EVs from severe COVID-19 and MIS-C. Functionally, severe COVID-19 EVs activated both NF-κB and IRF pathways, whereas MIS-C EVs preferentially activated IRF with minimal NF-κB signaling. Proteomics identified an MIS-C-specific EV cargo enriched for innate immune pathways, neutrophil degranulation, and adhesion/integrin-associated proteins. CONCLUSIONS: MIS-C is characterized by sustained humoral responses, TH17-skewed cytokines, and antigen-bearing EVs with distinct IRF-biased immunostimulatory and proteomic signatures. EV profiling and implicated pathways (eg, IL-17 and adhesion/integrin networks) may inform biomarker development and targeted immunomodulatory strategies in MIS-C.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Extracellular VesiclesImmunity, InnateHumansFemaleCytokinesMaleChildChild, PreschoolProspective StudiesAdolescentSystemic Inflammatory Response Syndrome

Stichwörter der Autor:innen

IL-17A/T(H)17IRF signalingMIS-Cextracellular vesiclesimmunothrombosisneutrophil degranulationpediatric COVID-19spike/RBD persistence

Substanzen

Cytokines

Autor:innen und Institutionen

  • Vaccine Development Research Program, Dokuz Eylul University, Izmir Biomedicine and Genome Center, Izmir, Turkiye; Molecular Biology and Genetics Department, Bilkent University, Ankara, Turkiye.
  • Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
  • Vaccine Development Research Program, Dokuz Eylul University, Izmir Biomedicine and Genome Center, Izmir, Turkiye.
  • Molecular Biology and Genetics Department, Bilkent University, Ankara, Turkiye.
  • Vaccine Development Research Program, Dokuz Eylul University, Izmir Biomedicine and Genome Center, Izmir, Turkiye; Department of Genomics and Molecular Biotechnology, Izmir International Biomedicine and Genome Institute…
  • Department of Pediatric Rheumatology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.

Förderung

  • TÜBİTAK

Zitieren

APA

Yildirim, T. C., Ozsurekci, Y., Yildirim, M., Yazar, V., Evcili, I., Gungor, B., Yilmaz, I. C., Ozen, S., Aykac, K., Cengiz, A. B., Guler, U., Salih, B., Gursel, M., & Gursel, I. (2026). Circulating extracellular vesicles drive innate immune dysregulation in MIS-C. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.02.048

Vancouver

Yildirim TC, Ozsurekci Y, Yildirim M, Yazar V, Evcili I, Gungor B, et al. Circulating extracellular vesicles drive innate immune dysregulation in MIS-C. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.02.048

BibTeX
@article{Yildirim2026,
  author = {Yildirim, Tugce Canavar and Ozsurekci, Yasemin and Yildirim, Muzaffer and Yazar, Volkan and Evcili, Irem and Gungor, Bilgi and Yilmaz, Ismail Cem and Ozen, Seza and Aykac, Kubra and Cengiz, Ali Bulent and Guler, Ulku and Salih, Bekir and Gursel, Mayda and Gursel, Ihsan},
  title = {Circulating extracellular vesicles drive innate immune dysregulation in MIS-C},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  doi = {10.1016/j.jaci.2026.02.048}
}
Kostenlos starten →